Saturday, November 23, 2024
Home > OT101

Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 – OT-101

Blockchain company Mateon Therapeutics (OTCQB:MATN)  has delivered the requisite testing results to Golden Mountain Partners (GMP) confirming the applicability and potential use of OT-101 for the treatment of COVID-19.Amit Shah, CFO of Mateon stated:“I am excited about the potential use of OT-101 against COVID-19. I congratulate the Mateon team on

Read More